| __timestamp | Galapagos NV | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 9079000 | 305409000 |
| Thursday, January 1, 2015 | 20309000 | 377080000 |
| Friday, January 1, 2016 | 16945000 | 432829000 |
| Sunday, January 1, 2017 | 20559000 | 496079000 |
| Monday, January 1, 2018 | 29641000 | 557616000 |
| Tuesday, January 1, 2019 | 88258000 | 658498000 |
| Wednesday, January 1, 2020 | 162170000 | 770456000 |
| Friday, January 1, 2021 | 167218000 | 840100000 |
| Saturday, January 1, 2022 | 239528000 | 944700000 |
| Sunday, January 1, 2023 | 94252000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability and growth. Over the past decade, Vertex Pharmaceuticals Incorporated and Galapagos NV have showcased contrasting strategies in this domain. From 2014 to 2023, Vertex Pharmaceuticals consistently outpaced Galapagos NV in SG&A spending, with a peak in 2023 where their expenses were approximately 12 times higher than Galapagos NV. This reflects Vertex's aggressive investment in administrative and sales capabilities, likely supporting their robust pipeline and market expansion. Meanwhile, Galapagos NV's SG&A expenses saw a significant rise in 2022, marking a 154% increase from 2014, indicating a strategic shift or expansion phase. Understanding these trends offers valuable insights into how these companies allocate resources to drive innovation and market presence.
Breaking Down SG&A Expenses: Johnson & Johnson vs Galapagos NV
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Amgen Inc. or Galapagos NV
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Insmed Incorporated or Galapagos NV
Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing MorphoSys AG and Galapagos NV
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Galapagos NV